BAQSIMI (nda210134)- (3MG)

Generic Name	GLUCAGON	Innovator	AMPHASTAR PHARMS INC
Dosage	3MG
ParaIV Filing	No	505(b)2 Filing	No
Last Patent Expiry	2039-Sep-23	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	2022-Jul-24
GAIN Expiry	None	Drug Complexity	No
Indication	BAQSIMI ™ is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 years and above.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
0	0	0

Other Developers

Total Other Developers	4

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
3MG	**	**	Down	-	-

Drug Sales

NDA Sales Available	Total Generic Sales Available
Yes	0

Manufacturing Details of BAQSIMI